{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:29:20Z","timestamp":1792459760094,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,8,31]],"date-time":"2000-08-31T00:00:00Z","timestamp":967680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2000,9,1]]},"DOI":"10.1038\/sj.leu.2401886","type":"journal-article","created":{"date-parts":[[2002,9,4]],"date-time":"2002-09-04T18:37:20Z","timestamp":1031164640000},"page":"1570-1576","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Treatment of children with early pre-B and pre-B acute lymphocytic leukemia with antimetabolite-based intensification regimens: a Pediatric Oncology Group Study"],"prefix":"10.1038","volume":"14","author":[{"given":"MB","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JJ","family":"Shuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MJ","family":"Borowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FG","family":"Behm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Camitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VJ","family":"Land","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2000,8,31]]},"reference":[{"key":"BF2401886_CR1","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1182\/blood.V84.9.3122.3122","volume":"84","author":"A Reiter","year":"1994","unstructured":"Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald D, Ritter J, Mann G, Welte K, Gadner H, Riehm H . Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86 Blood 1994 84: 3122\u20133133","journal-title":"Blood"},{"key":"BF2401886_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0140-6736(95)90164-7","volume":"345","author":"JM Chessells","year":"1995","unstructured":"Chessells JM, Bailey C, Richards SM . Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia Lancet 1995 345: 143\u2013148","journal-title":"Lancet"},{"key":"BF2401886_CR3","first-page":"99","volume":"26","author":"LF Sinks","year":"1981","unstructured":"Sinks LF, Wang JJ, Freeman AI . The treatment of primary childhood acute lymphocytic leukemia with intermediate dose methotrexate Hamatol Bluttransfus 1981 26: 99\u2013107","journal-title":"Hamatol Bluttransfus"},{"key":"BF2401886_CR4","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/1097-0142(19821215)50:12<2722::AID-CNCR2820501204>3.0.CO;2-T","volume":"50","author":"DM Green","year":"1982","unstructured":"Green DM, Brecher ML, Blumenson LE, Grossi M, Freeman AI . The use of intermediate dose methotrexate in increased risk childhood acute lymphoblastic leukemia Cancer 1982 50: 2722\u20132727","journal-title":"Cancer"},{"key":"BF2401886_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1056\/NEJM198303033080902","volume":"308","author":"AI Freeman","year":"1983","unstructured":"Freeman AI, Weinberg V, Brecher ML, Jones B, Glicksman AS, Sinks LF, Weil M, Pleuss H, Hananian J, Burgert EO Jr, Gilchrist GS, Necheles T, Harris M, Kung F, Patterson RB, Maurer H, Leventhal B, Chevalier L, Forman E, Holland JF . Comparison of intermediate-dose methotrexate with cranial irradiation for the post-induction treatment of acute lymphocytic leukemia in children New Engl J Med 1983 308: 477\u2013484","journal-title":"New Engl J Med"},{"key":"BF2401886_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/(SICI)1096-911X(199702)28:2<98::AID-MPO3>3.0.CO;2-N","volume":"28","author":"AI Freeman","year":"1997","unstructured":"Freeman AI, Boyett JM, Glicksman AS, Brecher ML, Leventhal BG, Sinks LF, Holland JF . Intermediate-dose methotrexate versus cranial irradiation in childhood acute lymphoblastic leukemia: a ten-year follow-up Med Pediatr Oncol 1997 28: 98\u2013107","journal-title":"Med Pediatr Oncol"},{"key":"BF2401886_CR7","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/1097-0142(19910201)67:3<550::AID-CNCR2820670303>3.0.CO;2-#","volume":"67","author":"RA Krance","year":"1991","unstructured":"Krance RA, Newman EM, Ravindranath Y, Harris MB, Brecher M, Wimmer R, Shuster JJ, Land VJ, Pullen J, Crist W, Pinkel D . A pilot study of intermediate-dose methotrexate and cytosine arabinoside, \u2018spread-out\u2019 or \u2018up-front\u2019, in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. A Pediatric Oncology Group study Cancer 1991 67: 550\u2013556","journal-title":"Cancer"},{"key":"BF2401886_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJM198609113151101","volume":"315","author":"LA Clavell","year":"1986","unstructured":"Clavell LA, Gelber RD, Cohen HJ, Hitchcock-Bryan S, Cassady JR, Tarbell NJ, Blattner SR, Tantravahi R, Leavitt P, Sallan SE . Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia New Engl J Med 1986 315: 657\u2013663","journal-title":"New Engl J Med"},{"key":"BF2401886_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1055\/s-2008-1033970","volume":"197","author":"UB Graubner","year":"1985","unstructured":"Graubner UB, Haas RJ, Janka G, Gaedicke G, Kohne E, Rieber EP . The Munich study on the treatment of acute lymphoblastic leukemia in childhood (ALL 77\u201302) Klin Padiatr 1985 197: 207\u2013214","journal-title":"Klin Padiatr"},{"key":"BF2401886_CR10","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1200\/JCO.1994.12.9.1939","volume":"12","author":"VJ Land","year":"1994","unstructured":"Land VJ, Shuster JJ, Crist WM, Ravindranath Y, Harris MB, Krance RA, Pinkel D, Pullen DJ . Comparison of two schedules of intermediate-dose methotrexate and cytarabine intensification therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study J Clin Oncol 1994 12: 1939\u20131945","journal-title":"J Clin Oncol"},{"key":"BF2401886_CR11","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.1200\/JCO.1998.16.8.2840","volume":"16","author":"MB Harris","year":"1998","unstructured":"Harris MB, Shuster JJ, Pullen DJ, Borowitz MJ, Carroll AJ, Behm FG, Land VJ . Intensification therapy with antimetabolite-based therapy in standard-risk acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study J Clin Oncol 1998 16: 2840\u20132847","journal-title":"J Clin Oncol"},{"key":"BF2401886_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1200\/JCO.1996.14.1.18","volume":"14","author":"M Smith","year":"1996","unstructured":"Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R . Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia J Clin Oncol 1996 14: 18\u201324","journal-title":"J Clin Oncol"},{"key":"BF2401886_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.1977.1","volume":"35","author":"R Peto","year":"1977","unstructured":"Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG . Design and analysis of randomized clinical trials requiring prolonged observation of each patient Br J Cancer 1977 35: 1\u201339","journal-title":"Br J Cancer"},{"key":"BF2401886_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation form incomplete observations J Am Stat Assoc 1958 53: 457\u2013481","journal-title":"J Am Stat Assoc"},{"key":"BF2401886_CR15","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/0197-2456(93)90003-V","volume":"14","author":"JJ Shuster","year":"1993","unstructured":"Shuster JJ . Fixing number of events in large comparative trials with low event rates: a binomial approach Control Clin Trials 1993 14: 198\u2013208","journal-title":"Control Clin Trials"},{"key":"BF2401886_CR16","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1200\/JCO.1994.12.4.740","volume":"12","author":"MA Schorin","year":"1994","unstructured":"Schorin MA, Blattner S, Gelber RD, Tarbell NJ, Donnelly M, Dalton V, Cohen HJ, Sallan SE . Treatment of acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute\/Children\u2019s Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85\u201301 J Clin Oncol 1994 12: 740\u2013747","journal-title":"J Clin Oncol"},{"key":"BF2401886_CR17","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJM199506153322407","volume":"332","author":"C-H Pui","year":"1995","unstructured":"Pui C-H . Childhood leukemias New Engl J Med 1995 332: 1618\u20131630","journal-title":"New Engl J Med"},{"key":"BF2401886_CR18","first-page":"1226","volume":"94","author":"WA Kamps","year":"1999","unstructured":"Kamps WA, Bokkerink JP, Hahlen K, Hermans J, Riehm H, Gadner H, Schrappe M, Slater R, van den Berg-de Ruiter E, Smets LA, de Vaan GA, Weening RS, van Weerden JF, van Wering ER, den der Does-van den Berg A . Intensive treatment of children with acute lymphoblastic leukemia according to ALL-BFM-86 without cranial radiotherapy: results of Dutch Childhood Leukemia Study Group Protocol ALL-7 (1988\u20131991) Blood 1999 94: 1226\u20131236","journal-title":"Blood"},{"key":"BF2401886_CR19","first-page":"A1807","volume":"34","author":"J Kurtzberg","year":"1993","unstructured":"Kurtzberg J, Asselin B, Poplack D, Grebanier A, Chen R, Franklin A, Scudiery D, Fisherman J . Antibodies to asparaginase alter pharmacokinetics and decrease enzyme activity in patients on asparaginase therapy (Meeting abstract) Proc Annu Meet Am Assoc Cancer Res 1993 34: A1807","journal-title":"Proc Annu Meet Am Assoc Cancer Res"},{"key":"BF2401886_CR20","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1200\/JCO.1993.11.9.1780","volume":"11","author":"BL Asselin","year":"1993","unstructured":"Asselin BL, Whitin JC, Coppola DJ, Rupp IP, Sallan SE, Cohen HJ . Comparative pharmacokinetic studies of three asparaginase preparations J Clin Oncol 1993 11: 1780\u20131786","journal-title":"J Clin Oncol"},{"key":"BF2401886_CR21","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1200\/JCO.2000.18.7.1525","volume":"18","author":"MH Woo","year":"2000","unstructured":"Woo MH, Hak LJ, Storm MC, Sandlund JT, Ribeiro RC, Rivera GK, Rubnitz JE, Harrison PL, Wang B, Evans WE, Pui C-H, Relling MV . Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia J Clin Oncol 2000 18: 1525\u20131532","journal-title":"J Clin Oncol"},{"key":"BF2401886_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/0006-2952(81)90082-4","volume":"30","author":"RC Jackson","year":"1981","unstructured":"Jackson RC, Hardkrader RJ . Synergistic and antagonistic interactions of methotrexate and 1-\u03b2-D-arabinofuranosylcytosine in hepatoma cells: the modulating effect of purines Biochem Pharmacol 1981 30: 223\u2013229","journal-title":"Biochem Pharmacol"},{"key":"BF2401886_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/BF00689278","volume":"27","author":"EM Newman","year":"1990","unstructured":"Newman EM, Villacorte DG, Testi AM, Krance RA, Harris MB, Ravindranath Y, Pinkel D . Biochemical interactions between methotrexate and 1-beta-D-arabinofuranosylcytosine in hematopoietic cells of children: a Pediatric Oncology Group study Cancer Chemother Pharmacol 1990 27: 60\u201366","journal-title":"Cancer Chemother Pharmacol"},{"key":"BF2401886_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1172\/JCI109525","volume":"64","author":"E Cadman","year":"1979","unstructured":"Cadman E, Eifman F . Mechanism of synergistic cell killing when methotrexate precedes cytarabine: study of L1210 and human leukemic cells J Clin Invest 1979 64: 788\u2013797","journal-title":"J Clin Invest"},{"key":"BF2401886_CR25","first-page":"331","volume":"2","author":"ML Graham","year":"1996","unstructured":"Graham ML, Shuster JJ, Kamen BA, Land VJ, Borowitz MJ, Camitta B, Cheo DL, Harrison MP, Leventhal BG, Pinkel DP, Pullen DJ, Steuber P, Whitehead VM . Changes in red blood cell methotrexate pharmacology and their impact on outcome when cytarabine is infused with methotrexate in the treatment of acute lymphocytic leukemia in children: a Pediatric Oncology Group study Clin Cancer Res 1996 2: 331\u2013337","journal-title":"Clin Cancer Res"},{"key":"BF2401886_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1182\/blood.V76.1.117.117","volume":"76","author":"Crist WM","year":"1990","unstructured":"WM Crist, AJ Carroll, JJ Shuster, FG Behm, M Whitehead, TJ Vietti, AT Look, D Mahoney, A Ragab, DJ Pullen . Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study Blood 1990 76: 117\u2013122","journal-title":"Blood"},{"key":"BF2401886_CR27","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1200\/JCO.1990.8.8.1380","volume":"8","author":"Raimondi SC","year":"1990","unstructured":"SC Raimondi, FG Behm, PK Roberson, DL Williams, CH Pui, WM Crist, AT Look, Rivera GK . Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19) J Clin Oncol 1990 8: 1380\u20131388","journal-title":"J Clin Oncol"},{"key":"BF2401886_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1200\/JCO.1998.16.2.527","volume":"16","author":"FM Uckun","year":"1998","unstructured":"Uckun FM, Sensel MG, Sather HN, Gaynon PS, Arthur DC, Lange BJ, Steinherz PG, Kraft P, Hutchinson R, Nachman JB, Reaman GJ, Heerema NA . Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report of the Children\u2019s Cancer Group J Clin Oncol 1998 16: 527\u2013535","journal-title":"J Clin Oncol"},{"key":"BF2401886_CR29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJM199806043382304","volume":"338","author":"JB Nachman","year":"1998","unstructured":"Nachman JB, Sather HN, Sensel MG, Trigg ME, Cherlow JM, Lukens JN, Wolff L, Uckun FM, Gaynon PS . Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy New Engl J Med 1998 338: 1663\u20131671","journal-title":"New Engl J Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2401886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401886","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2401886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:45:03Z","timestamp":1648763103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2401886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,31]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9,1]]}},"alternative-id":["BF2401886"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2401886","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8,31]]},"assertion":[{"value":"31 August 2000","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}